DCTH logo

DCTH
Delcath Systems Inc

26,278
Mkt Cap
$316.89M
Volume
494,144.00
52W High
$18.23
52W Low
$8.12
PE Ratio
145.45
DCTH Fundamentals
Price
$9.37
Prev Close
$9.12
Open
$9.16
50D MA
$9.86
Beta
1.23
Avg. Volume
562,182.37
EPS (Annual)
$0.0676
P/B
2.84
Rev/Employee
$546,352.56
$313.09
Loading...
Loading...
News
all
press releases
Propel Bio Management LLC Buys 212,457 Shares of Delcath Systems, Inc. $DCTH
Propel Bio Management LLC grew its stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 94.0% during the third quarter, according to its most recent filing with the Securities and...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
Delcath Systems, Inc. (Nasdaq: DCTH), (Delcath or the Company) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of...
Business Wire·8d ago
News Placeholder
FY2029 EPS Forecast for Delcath Systems Decreased by Analyst
Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) - Equities researchers at HC Wainwright dropped their FY2029 EPS estimates for shares of Delcath Systems in a note issued to investors on Monday...
MarketBeat·8d ago
News Placeholder
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat...
MarketBeat·9d ago
News Placeholder
Delcath Systems (NASDAQ:DCTH) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen lowered shares of Delcath Systems from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·11d ago
News Placeholder
Delcath Systems Q4 Earnings Call Highlights
Delcath Systems (NASDAQ:DCTH) reported record results for 2025 and outlined a commercial and clinical roadmap that management believes can support continued growth, emphasizing expanding...
MarketBeat·13d ago
News Placeholder
BTIG Research Cuts Delcath Systems (NASDAQ:DCTH) Price Target to $19.00
BTIG Research reduced their target price on shares of Delcath Systems from $23.00 to $19.00 and set a "buy" rating for the company in a report on Thursday...
MarketBeat·13d ago
News Placeholder
Delcath Systems Q4 Earnings Assessment
read more...
Benzinga·13d ago
News Placeholder
Delcath Systems Reports Fourth Quarter and Full Year 2025 Results
Delcath Systems, Inc. (Nasdaq: DCTH) (Delcath or the Company), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial...
Business Wire·13d ago
News Placeholder
Delcath Systems (DCTH) to Release Earnings on Thursday
Delcath Systems (NASDAQ:DCTH) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...
MarketBeat·13d ago
<
1
2
...
>

Latest DCTH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.